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Abstract: Activated transcription of the human neuro-
peptide Y gene (NPY) was investigated in SH-SY5Y neu-
roblastoma cells at the onset of sympathetic neuronal
differentiation induced by 1 2-O-tetradecanoylphorbol 13-
acetate (TPA) and serum or by nerve growth factor
(NGF). As determined by transient expression, two NGF
response elements (REs) were required for transcription
induced by NGF in SH-SY5Y cells with stable expression
of an exogenous NGF receptor TRK-A gene (SH-SY5Y/
trk). TPA treatment in the presence of serum induced
NPY transcription in both wild-type SH-SY5Y (SH-SY5Y/
wt) and SH-SY5Y/trk cells. A TPA RE (TRE), overlapping
the proximal NGF RE, was identified by expression of
the v-Jun oncoprotein that enhanced NPY transcription.
Suppression of TPA-induced NPY transcription was ob-
tained by expression of a dominant negative Jun protein,
selective protein kinase C inhibition, or introduction of a
mutated TRE, whereas NGF-induced NPY transcription
was inhibited to a lesser degree. The transcription factor
AP-2cs was shown to bind cooperatively to the NPY pro-
moter with either AP-1 or NGFI-A to the shared TRE and
NGF RE and to the distal NGF RE, respectively. These
results show that transcription factors AP-1, AP-2a, and
NGFI-A are involved in activated NPY transcription during
the onset of neuronal differentiation. Key Words: Neuro-
peptide Y—Transcription —SH-SY5Y neuroblastoma—
AP-1 —AP-2a—NGFI.
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transcribed in response to membrane depolarization in
PC12 cells (Higuchi et al., 1996). Both transcriptional
and posttranscriptional mechanisms appear to be oper-
ative for maximal NPY gene expression in PC12 cells
in response to combined treatment with phorbol ester
and forskolin. However, mainly posttranscriptional ef-
fects are activated in response to this treatment in LA-
N-5 neuroblastoma cells (Lerchen et al., 1995). In
fact, an NGF responsive element (RE) in the human
NPY promoter, located between positions —87 and
—36 relative to the start site for transcription, was pre-
viously identified (Minth-Worby, 1994).
Treatment of human SH-SY5Y wild-type (SH-
SY5Y/wt) neuroblastomacells with namomolarconcen-
trations of the phorbol ester 12-O-tetradecanoylphorbol
13-acetate (TPA) in serum-containing medium acti-
vates sustained protein kinase C (PKC ) -dependent sig-
nal transduction events, leading to differentiation into a
functional neuronal sympathetic phenotype (P~ihlmanet
al., 1981, 1984, 1991, 1992, 1995; Parrow et al., 1992).
The novel PKC isoform nPKC-e was recently impli-
cated in neurite outgrowth in these cells (Fagerstrom
et al., 1996). NPY gene transcription in SH-SY5Y/wt
neuroblastoma cells is induced following activated PKC
signaling (P~hlmanet al., 1991; Andersson et al., 1994;
Jalava and Mai, 1994). A rapid synchronous and bipha-
Neuropeptide Y gene (NPY) expression in response
to treatment with phorbol ester, nerve growth factor
(NGF), and forskolin has been extensively studied in
both neuroblastoma and PC 12 pheochromocytoma
cells (Minth et al., 1986; Allen et al., 1987; Higuchi
et al., 1988; Minth and Dixon, 1990; Sabol and Hi-
guchi, 1990; Andersson et al., 1994; Balbi and Allen,
1994; Jalava and Mai, 1994; Minth-Worby, 1994).
Recently, the rat NPY gene was shown to be actively
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sic induction of c-fos and c-jun mRNA expression is
obtained by treatment of SH-SY5Y/wt cells with TPA
(Hammerling et al., 1987; Andersson et al., 1994). The
second peak of c-fos and c-jun gene transcription cone-
lates with maximal NPY gene transcription as well as
with the onset of functional neuronalsympathetic differ-
entiation. TPA-induced interactions of the activatorpro-
tein 1 (AP- 1) family of transcription factors and of AP-
2a to a TPA RE (TRE) in the NPY promoter were
identified in SH-SY5Y/wt nuclear extracts. Unlike the
TPA-induced c-jun rnRNA expression, AP-2cx mRNA
is constitutively expressed in SH-SY5Y/wt cells (An-
dersson et al., 1994). NPY transcription in SH-SY5Y/
wt cells in response to PKC signaling is likely to be
activated by cooperation between the transcription fac-
tors AP-1 and AP-2a (Andersson et al., 1994). Thus,
transcriptional as well as posttranscriptional mecha-
nisms activated by PKC appear to be important for the
induced NPYgene transcription in differentiating neuro-
blastoma cells.
SH-SY5Y/wt cells express both the high-affinity
(pl
4Øc.trk.A) as well as the low-affinity (p75) NGF
receptor (Azar et al., 1990; Lavenius et al., 1995).
Even so, SH-SY5Y/wt cells, like other cultured neuro-
blastoma cells, do not show NGF responsiveness, indi-
cating a defective TRK-A-dependent signal transduc-
tion or low receptor levels (Lavenius et al., 1994,
1995). Stable expression of an exogenous functional
TRK-A gene in the SH-SY5Y cell line (SH-SY5Y/trk)
allows these cells toundergo neuronal sympathetic dif-
ferentiation and to express NPY after exposure to NGF
(Lavenius et al., 1995). Therefore, SH-SY5Y/trk cells
offer an advantageous biological system to study dis-
tinct effects of NGF and TPA on NPY gene transcrip-
tion.
To compare the mechanisms responsible for acti-
vated NPY gene expression in SH-SY5Y/wt and SH-
SY5Y/trk cells in response to TPA and NGF treat-
ments, we have performed transient transfection analy-
ses withNPYpromoter targetplasmids. Transcriptional
activation was studied under conditions where PKC
and AP- 1 activities were either positively or negatively
modulated. Furthermore, DNA-protein binding analy-
ses identified transcription factors of importance for
the TPA- and NGF-dependent regulation of NPY gene
expression in these two cell types.
EXPERIMENTAL PROCEDURES
Cell cultures
The human neuroblastoma cell line SH-SYSY/wt, a sub-
clone of the cell line SK-N-SH (Biedler et a!., 1978), was
kindly provided by Dr. J. Biedler (Sloan Kettering Institute,
New York, NY, U.S.A.). The establishment of the stable
TRK-A-transfected SH-SY5Y/trk cell clone 6:2 has been
described (Lavenius et al., 1995). The cells were cultured
in Eagle’s minimum essential medium in the presence of
10% fetal calf serum (GIBCO, Gaithersburg, MD, U.S.A.),
penicillin (100 IU/ml), and streptomycin (50 ~sg/ml). Con-
ditions for induction of differentiation of these cell lines
have been described (Pithlman et al., 1981, 1984; Lavenius
et al., 1995). In brief, SH-SY5Y/wt and SH-SY5Y/trk cells,
at low density (1—2 x iO~cells/8.5-cm Petri dish), were
induced with 16 nM TPA in fetal calf serum-containing
medium. Alternatively, SH-SY5Y/trk cells were induced
with 100 ng/ml of mouse NGF 2.5S (Promega, Madison,
WI, U.S.A.). Prior to TPA or NGF treatment, cells were
grown in serum-containing Eagle’s medium for 24 h. Stock
solutions of TPA (Sigma Chemical Co., St. Louis, MO,
U.S.A.) were prepared in ethanol. The final ethanol concen-
tration was kept below 0.1 % in all experiments. The selective
PKC inhibitor GF 109203X (Toullec et al., 1991) was used
at a concentration of 2 pM when indicated and added 30
mm prior to TPA or NGF (Fagerstrom et al., 1996).
Northern hybridization
RNA was isolated essentially as previously described
(Auffray and Rougeon, 1980) with minor modifications
(Hammerling et al., 1987). Purification of poly(A)~
mRNA, electrophoresis, and northern analysis were per-
formed as outlined (Hammerling et a!., 1987) except that
Hybond-C membranes (Amersham Int., Amersham, Buck-
inghamshire, U.K.) were used. mRNA was quantified by
absorbance at 260 nm. Human NPY, NGFI-A, and NGFI-C
(gift from Dr. J. Milbrandt, Washington University, St.
Louis, MO, U.S.A.) cDNA probes (Minth et a!., 1986;
Crosby et al., 1991) were used in these experiments. A
cDNA probe encoding the human glyceraldehyde-3-phos-
phate dehydrogenase (pHcGAP3; a gift from Dr. R. Wu,
Cornell University, Ithaca, NY, U.S.A.) served as quantita-
tive standard for the amount of mRNA loaded measured by
phosphonmage analyses using Fuji BAS 2000 equipment
(Fuji, Japan). eDNA probes were labeled according to the
manufacturer (Amersham).
Transient expression assays
Transfections shown in Fig. 4B were performed with the
calcium phosphate technique as described (Chen and Oka-
yama, 1987). All other transfections were performed with
theDEAE-dextran chloroquine bisphosphate method as pre-
viously described (Sompayrac and Danna, 1981; Andersson
et al., 1994). The NPY promoter target plasmids used in this
study have already been described (Minth-Worby, 1994).
In brief, 15 ~sgof each plasmid target DNA was used in the
experiments. In co-transfection experiments, 2 and 5 ~ig of
a dominant negative v-jun plasmid denoted z~9(Lloyd et
al., 1991) or 2 ~sgof a v-jun activator plasmid (Baichwal
and Tjian, 1990) was used as indicated. Five million un-
treated SH-SY5Y/wt or SH-SY5Y/trk cells were transfected
on each plate. Before addition of TPA or NGF, the cells
were allowed to recover for 24 h. After treatment with addi-
tives for an additional 24 h, the cells were harvested and
lysates were prepared for chloramphenicol acetyltransferase
(CAT) assays. Fifty micrograms of protein was used in each
CAT assay at 37°Cfor 16 h. TheCAT values were quantified
by phosphorimage analyses (Fuji BAS 2000) and normal-
ized to the activity obtained by positive and negative control
target plasmids. Each transfection was performed in either
duplicate or triplicate more than three times using different
plasmid preparations. Errorbars indicate the standard devia-
tions from the means. Results were standardized, where val-
ues for uninduced resting cells were set to 1. In parallel
transfection assays, pRSVCATwas used as thepositive (Gor-
man et al., 1982) and pTKCAT (Tsang et a!., 1988; Minth-
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Worby, 1994) served as the negative control plasmids.
Transfection efficiency was evaluated by comparison of the
CAT activities with these plasmids in multiple independent
transfections.
Preparation of nuclear protein extracts
Nuclear extracts were prepared from SH-SY5Y/wt and
SH-SY5Y/trk cells as described (Andrews and Faller,
1991). Cells were harvested on ice and washed with phos-
phate-buffered saline, and cell pellets were resuspended in
400 ~i! of isotonic bufferA [10 mM HEPES-KOH (pH 7.9),
10 mM KC1, 1.5 mM MgC12, 0.5 mM dithiothreitol (DTT),
0.2 mM phenylmethylsulfonyl fluoride (PMSF)]. After in-
cubation on ice for 10 mm, cells were vortexed and centri-
fuged. Nuclei were collected, resuspended in cold buffer C
[20 mM HEPES-KOH (pH 7.9), 420 mM NaC1, 1.5 mM
MgC12, 10 mM KC1, 0.2 mM EDTA, 0.2 mM PMSF, 25%
glycerol, 0.5 mM DTT], and incubated on ice for 20 mm.
Debris was removed by a short centrifugation. Protein con-
centration was determined using the Bio-Rad system (Bio-
Rad Scandinavia, Sweden). The nuclear extracts were ali-
quoted, frozen in liquid nitrogen, and stored at —70°C.
DNA-protein binding assays
Electrophoretic mobility shift assay (EMSA) (Fried and
Crothers, 1981) was performed using SH-SY5Y/wtand SH-
SY5Y/trk nuclear extracts. The extracts were first quality
tested using an AP- 1 oligonucleotide, and comparable pro-
tein-DNA complexes to those obtained previously were ob-
served. The conditions for protein-DNA binding were ac-
cording to Minth-Worby (1994) to allow.comparison with
complexes obtained in PC12 nuclear extracts. In brief,
20,000 cpm of
32P radioactively !abel d double- tranded oh-
gonucleotides was incubated with 4 ~ig of SH-SY5Y/wt
or SH-SY5Y/trk nuclear extracts prepared from control or
stimulated cells in a binding buffer [10 mM HEPES (pH
7.9), 50 mM KC1, 1 mM EDTA, 5 mM DTT, 5 mM MgC1
2,
10% glycerol]. Two micrograms of polydeoxyinosinic—
deoxycytidylic acid (Pharmacia & Upjohn, Uppsala, Swe-
den) was included as competitor for nonspecific DNA-pro-
tein interaction in each reaction. Specific competition was
monitoredusing 100- to 200-fold molarexcess of nonlabeled
double-stranded oligonucleotides as indicated. The oligonu-
c!eotides used are listed in Table 1. For antibody interference
and supershift experiments, 1 ~.tlof undiluted or 1 ,ul of 0.1 X
diluted antiserum against AP-2a (sc-184 X), c-Fos (sc-52
X), c-Jun (sc-45 X), JunD (sc-74 X), and c-Jun/AP-l (D)
[a-Jun (sc-44 X); Santa Cruz Biotechnology, Santa Cruz,
CA, U.S.A.], as indicated in the legends to Figs. 5 and 6,
either was added to the nuclear extracts 1 h before addition
oflabeled oligonucleotide or was added after incubation with
labeled oligonucleotide and incubated 1 h on ice. Binding
reactions were incubated at room temperature for 30 mm
and then separated on 5% nondenaturing polyacrylamide
gels (29:1 acrylamide/bisacrylamide) in either aTGE buffer
(50 mM Tris, 0.38 mM glycine, 2 mM EDTA) (Fig. 5A)
or a TBE buffer [22 mM Tris-borate (pH 8.3), 0.05 mM
EDTA] (Figs. SB and 6). After electrophoresis at 4°C,the
gels were dried and visualized by phosphorimage analysis
or by standard autoradiography at —70°C using Kodak X-
Omat film (Kodak AB, Jarfrilla, Sweden). The plasmid
pJDM15O2 (provided by Dr. J. Milbrandt), containing the
rat NGFI-A gene inserted in thepCITE1 mammalian expres-
sion vector (Novagen, Madison, WI, U.S.A.), was digested
with Sal! to generate a linearized DNA template. Coupled in
vitro transcription and translation in TNT-T7-coupled rabbit
reticulocyte lysates (Promega) according to the manufactur-
er’s instructions were performed using this DNA template.
One microliter of the total 50-js! reaction mixture of in vitro
translated NGFI-A was used in EMSA with an oligonucleo-
tide containing the GSG-1 and GSG-2 boxes (oligonucleo-
tide no. 5 in Table 1).
RESULTS
Enhanced NPY, NGFI-A, and NGFI-C mRNA
expression in SH-SY5YItrk cells in response to
NGF treatment
Northern hybridization experiments were performed
to determine NPY mRNA expression profiles in SH-
SYSY/wt and SH-SY5Y/trk cells. mRNA was pre-
pared from untreated SH-SY5Y/trk cells and after
treatment with 100 ng/ml of NGF for indicated times
(Fig. 1A). Exposure of SH-SY5Y/trk cells to NGF
leads to an induction pattern of NPY mRNA compara-
ble with that obtained in SH-SY5Y/wt cells after TPA
treatment (Fig. 1A) (Andersson eta!., 1994). Maximal
NPY mRNA expression was detected 4 days after NGF
treatment in this analysis (Fig. 1A).
Defective NGF responsiveness in SH-SY5Y/wt
cells has previously been monitored by examination
of c-fos mRNA expression following NGF treatment.
Both c-fos and c-jun mRNA levels in SH-SY5Y/wt
cells were unaffected by NGF treatment, whereas en-
hanced expression was shown in SH-SY5Y/trk cells
(Lavenius et a!., 1995; data not shown).
To determine the mRNA expression pattern of the
NGF-inducible immediate early NGFI-A and NGFI-C
genes (Swirnoff and Milbrandt, 1995), mRNA was
prepared from untreated SH-SY5Y/trk cells and, after
treatment with either 100 ng/ml of NGF or 16 nM
TPA for the indicated times, hybridized with NGFI-A
and NGFI-C eDNA probes. In resting SH-SY5Y/trk
cells, inRNA expression of these genes was undetect-
able (Fig. 1B). A synchronous and transient induction
of these immediate early genes was obtained with both
NGF and TPA treatments. Maximal expression was
seen after 1-h treatment. Further, TPA treatment led
to stronger and more persistent induction in compari-
son with NGF treatment (Fig. 1B). A second minor
peak of NGFI-A mRNA expression was reproducibly
seen after 12 h of TPA and NGF treatment (Fig. 1 B).
Transcription of NPY gene is activated in
response to NGF in SH-SY5Y/trk cells
To determine whether the observed NPY mRNA in-
duction reflects a transcriptional activation, transient
transfection analyses were performed in SH-SY5Y/wt
and SH-SY5Y/trk cells. Cells were transfected with
a target plasmid containing NPY promoter sequences
between positions —87 and —47 cloned in front of a
heterologous thymidine kinase (TK) promoter and the
bacterial CAT gene. This region of the rat and human
NPY promoters spans an NGF RE as previously de-
fined in PC12 cells (Higuchi et al., 1992; Minth-
J. Neurochem., Vol. 70, No. 5, 1998
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TABLE 1. Nucleotide sequences of oligonucleotides used in EMSA
No. Sequence
1 —731—45: 5 ‘-GCGTGACTGCCCGAGGCCCCTCCTGCCGC-3’
2 —871—56: 5 ‘-GGGAGTCACCCAAGCGTGACTGCCCGAGGC-3’








1—3: oligonucleotides corresponding to the human NPY promoter. 1, positions —73 to —45; 2, positions
—87 to —56. Oligonucleotides 1 and 2 contain partially overlapping sequences. 3, positions as in 2 where
the AP- 1 site is mutated. Mutated positions are underlined. 4, oligonucleotide containing an AP- I site from
the human DRA gene promoter corresponding to positions —100 to —87 (Andersson and Peterlin, 1990).
5, ohigonucleotide containing two GSG elements corresponding to positions —195 to —173 in the NPY
promoter. 6, ohigonucleotide where the GSG elements are mutated. Mutated positions are underlined. 7,
oligonucleotide containing two AP-2 binding sites from thehuman metallothionein hA promoter (Imagawa
et al., 1987). 8, oligonucleotide with two 16-bp tandem copies containing SpI consensus binding sites from
the herpes simplex virus IE-3 gene promoter (Westin and Schaffner, 1988). All oligonucleotides were
synthesized with BamHIJBglII sticky ends for the purpose of radioactive labeling. Only the sense strands
of the double-stranded oligonucleotides are shown.
Worby, 1994). This NGF RE contains several cis ele-
ments with implications for phorbol ester- and NGF-
dependent transcription (Fig. 2). In particular, two AP-
1-like sites (5 ‘-GGAGTCA-3’, 5 ‘-TGACTGC-3’) are
present in the NPY promoter. Moreover, an AP-2 site
(5’-GCCCGAGGC-3’) is located 5’ of the CT box
that binds Spi family proteins (Andersson et al., 1994;
Minth-Worby, 1994) (Fig. 2). Following a recovery
period after transfections, SH-SY5Y/wt and SH-
SY5Y/trkcells were stimulated withNGF for 24 h, or,
as a control for basal activity, cells were not exposed to
any reagent (see Experimental Procedures). In SH-
SY5Y/wt cells, NGF treatment did not significantly
increase the CAT activity above the control level,
whereas a pronounced (ninefold) induction was ob-
tained in response to NGF in SH-SY5Y/trk cells (Fig.
3A). As expected, TPA treatment induced NPY pro-
moter activity in both SH-SY5Y/wt and SH-SY5Y/
FIG. 1. Northern blotting analysis of NPY, NGFI-A, and NGF!-C mRNA expression in SH-SY5Y/trk cells. A: mRNA was prepared from
nontreated cells and from cells treated with 100 ng/ml NGF for indicated times. Northern filters were probed for NPY and GAPDH,
and hybridization signals were visualized by phosphorimage analysis. B: mRNA was prepared from resting cells (0) and from cells
treated with either 16 nM TPA or 100 ng/ml of NGF for indicated times. Northern filters were probed for NGFI-A and NGFI-C, and
hybridization signals were visualized by phosphorimage analysis and presented in a diagram with arbitrary units (arb units).
J. Neurochem., Vol. 70, No. 5, 1998
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FIG. 2. Schematic diagram of cis ele-
ments and DNA binding activities to the
NGF REs of the human NPY promoter.
DNA binding activities located within the
NGF REs are indicated. The 5’ and 3’ bor-
ders of the oligonucleotides used for
EMSA(no. 1, —73/—45; no.2, —871--56;
no. 5, —195/—173) are indicated below
the sequence. The borders of the GSG-3
element are also indicated.
trk cells (Fig. 3A). The relatively higher induction
observed in SH-SY5Y/wt cells than in SH-SY5Y/trk
cells reflects a higher basal NPY transcription in SH-
SY5Y/trk cells. Note that in resting SH-SY5Y/trk
cells, NPY mRNA expression is higher than in resting
SH-SY5Y/wt cells (Fig. 1A) (Andersson et al.,
1994). Thus, this part of the NPYpromoter is essential
for TPA activation in both cell types and activated
transcription of the NPY gene induced by NGF in SH-
SY5Y/trk cells.
NGF-dependent transcriptional activation of NPY
gene in differentiating SH-SY5Y/trk cells
To investigate the NPY promoter sequences respon-
sible for the activation by NGF in differentiating SH-
SY5Y/trk cells, transient transfections were performed
with NPY targets carrying successive deletions of the
NPY promoter. The following NPY promoter deletion
constructs were used: positions —246, —118, —83,
—63, and —51. In addition, all plasmids contained 51
nucleotides of the NPY5 ‘-UTexon (see Minth-Worby,
1994; also Experimental Procedures). Following a re-
covery period after the transfections, cells were sub-
jected to stimulation with NGF for 24 h, or, as a con-
trol, cells were not exposed to any reagents. Treatment
of SH-SY5Y/wt cells with NGF did not induce CAT
activities of any of the NPY promoter targets (data not
shown). Maximal NGF responsiveness in SH-SY5Y/
trk cells was obtained with the —246 NPYCAT target
plasmid (fourfold). Successive deletions of the NPY
promoter led to decreased activities. A weak NGF re-
sponsiveness was obtained with the —83 NPYCAT tar-
get plasmid. Deletion to position —63 abolished the
NGF induction (Fig. 3B). At positions —193 to —176
in the distal NGF RE, two GSG-like-elements were
identified (Fig. 2). GSG sequences have been reported
to bind NGFI proteins (Swirnoff and Milbrandt,
1995). Thus, we conclude that NGF-inducible tran-
scription of the NPY gene involves these GSG pro-
moter elements.
TPA-dependent transcriptional activation of NPY
gene is abolished by mutations of proximal AP-1-
like site or distal AP-2 site
To determine the effects of the TPA treatment on
the expression from the NPY promoter, transient ex-
pression assays with the wild-type —246 NPYCAT tar-
get plasmid as well as two target plasmids bearing
clustered point mutations in the context of the —246
NPYCAT target were performed. The mutant NPY tar-
gets either abolish the AP-1-like site (5 ‘-TGACTGC-
3’) or destroy the AP-2 site (5’-GCCCGAGGC-3’)
(see Fig. 2). The basal activities of the mutated target
plasmids were lower than those of the wild-type target,
and TPA-mediated induction could not be obtained
when either of the mutated target plasmids was ana-
lyzed (not shown). Thus, both the AP-l-hike and the
distal AP-2 site are essential for activated transcription
of the NPY gene induced by TPA in SH-SY5Y cells.
Overexpression of v-Jun enhances transcriptional
activation of NPY gene in SH-SY5YIwt cells
Todirectly address Jun-dependent NPY transcription
activation in SH-SY5Y/wt cells, the —877—47 NPY/
TKCAT target plasmid, which contains the two AP- I -
like sites (5’-GGAGTCA-3’, 5’-TGACTGC-3’), was
co-transfected with a v-jun activator (Baichwa! and
Tjian, 1990) in resting SH-SY5Y/wt cells. Overex-
pression of v-Jun led to fivefold relative induction of
CAT activities in these SH-SY5Y/wt cells (Fig. 4A).
Similar results were obtained with SH-SY5Y/trk cells
(not shown).
A dominant negative Jun protein suppresses
PKC-dependent NPY expression, whereas NGF-
induced activation is inhibited to lesser degree
To further analyze the effects of Jun on NPYexpres-
sion, the —877—47 NPY/TKCAT target plasmid was
co-transfected with increasing amounts of ~9, which
directs the synthesis of a dominant negative Jun protein
(Lloyd et al., 1991 ), in either TPA-stimulated or NGF-
stimulated SH-SY5Y/trk cells. This mutated form of
J. Neurochem., Vol. 70, No. 5, /998
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FIG. 3. A: Transient transfection analyses of the —87/—47 NPY/
TKCAT reporter plasmid. Open columns represent the normal-
ized CAT activities obtained from transient transfections of un-
treated SH-SY5Y/wt and SH-SY5Y/trk cells with the —87/—47
NPY/TKCAT reporter plasmid. Filled columns represent the rela-
tive CAT induction obtained following TPA treatment. Hatched
columns represent the relative CAT induction obtained in re-
sponse to NGF treatment. B: Transient transfection analyses of
NPY/CAT promoter deletion plasmids. Open columns represent
the normalized CAT activities obtained from transient transfec-
tions of untreated SH-SY5Y/trk cells with NPY deletion plasmids
with deletions ranging from —246 to —51. Hatched columns rep-
resent the relative induction in response to treatment with 100
ng/ml of NGF 24 h prior to harvest. Data represent an average
of three transfections for each plasmid. The error bars represent
the standard deviation from the mean.
Jun lacks the transcriptional activation domain and
blocks Jun-dependent transcription and transformation
activities (Lloyd et al., 1991). The L~9plasmid has
previously also been shown to effectively inhibit c-
Jun-dependent collagenase transcription in normal and
ras-transformed fibroblasts (Shoshan and Linder,
1994). The overexpression of z~9in SH-SY5Y/trk
cells resulted in ~—~85and 70% decreased NPY pro-
moter activities of the TPA- and NGF-dependent activ-
ities, respectively, when the highest amounts of the
L~9plasmid were co-transfected (Fig. 4B). Specificity
of the z~9plasmid was controlled by co-transfection
with a pRSVCAT target plasmid. Transcription driven
by the RSV promoter was not inhibited by the z~9
plasmid in either control or TPA-treated cells (not
shown). Weconclude from these experiments that pro-
teins of the Jun family of transcription factors are nec-
essary for the increased transcription of the NPY gene
in activated SH-SY5Y cells and that Jun binding is
mediated by the AP- 1-like sites.
Selective PKC inhibition suppresses NPY
expression in SH-SY5Y/trk cells in response to
TPA but only partially in response to NGF
Treatment of SH-SY5Y/trk cells with the selective
PKC inhibitor GF 109203X (Toullec et al., 1991)
should reveal PKC-dependent transcriptional activities
of the NPY promoter. Therefore, SH-SY5Y/trk cells
were transfected with the —87/—47 NPY/ TKCA T tar-
get plasmid, and 30 mm before addition of either TPA
or NGF, the cells were treated with 2 ~uMGF 109203X,
which revealed that the basal NPY promoter activity
was unaffected by the PKC inhibitor (Fig. 4C). In
contrast, GF 109203X treatment resulted in 87 and
40% suppression of the transcriptional activation of
NPY in response to TPA and NGF, respectively (Fig.
4C). Thus, activated PKC signaling appears to be re-
quired for NPY transcription. Activation of this path-
way was less important during NGF-evoked NPY tran-
scription.
Analyses of proteins that bind to —87/—56 region
of NPY promoter in SH-SY5Y nuclear extracts
Previously, EMSA was used to identify TPA-en-
hanced AP-1 and AP-2 DNA binding activities in SH-
SY5Y/wt nuclear extracts using an oligonucleotide
corresponding to the evolutionarily conserved region
at position —73/—45 (oligonucleotide no. 1 in Table
1) of the human NPY promoter (Andersson et al.,
1994). In the present study, an oligonucleotide corre-
sponding to the proximal NGF RE at position —87/
—56 (no. 2 in Table 1 and Fig. 2) containing the two
AP- 1-like sites and the distal AP-2 binding site was
analyzed by EMSA and compared with the complexes
(CI to CIV) (Andersson et al., 1994) obtained with the
—73 /—45 oligonucleotide (no. 1 in Table 1). Nuclear
extracts from resting, NGF-treated, and TPA-treated
SH-SY5Y/wt and SH-SY5Y/trk cells were analyzed.
No major qualitative differences were seen in the dif-
ferent nuclear extracts (not shown). Three DNA bind-
ing activities denoted C-A to C-C were obtained in
SH-SY5Y/trk nuclear extracts using the —87/—56 oh-
gonucleotide (Fig. 5A, lane D). The complexes ob-
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tamed with the —737—45 and the —877—56 ohigonu-
cleotides in SH-SY5Y/trk nuclear extracts were com-
pared. This revealed that neither C-B nor C-A could
be formed with the —737—45 oligonucleotide (Fig.
5A, lane A). A co-migration between CII and C-C
was observed (Fig. 5A, lanes C and D). Moreover, the
—877—56 oligonucleotide (no. 2 in Table 1) competed
only for CI and CII complexes formed with the —73/
—45 oligonucleotide (Fig. 5A, laneB). The abundance
of C-B and C-A was similar, whereas the abundance
of C-C differed between nuclear extract preparations.
Compare Fig. 5A and B. The DNA binding activities
of these complexes in response to TPA and NGF treat-
ment of SH-SY5Y/wt and SH-SY5Y/trk cells, respec-
tively, were, in principle, unaffected (not shown).
Competition of the C-B and C-C complexes was ob-
tained with both oligonucleotide no. 1 (Table 1) and
the ohigonucleotide containing a mutation at position
—737—67 (no. 3 in Table 1), whereas C-A formation
was unaffected by these oligonucleotides (Fig. 5A,
lanes E and F). Competition using the —737—45 oligo-
nucleotide for —877—56 binding resulted in the disap-
pearance of C-B and C-C (Fig. 5A, lane E).
AP-2a and JunB participate in complex
formation in SH-SY5Y/wt nuclear extracts
To determine whether AP- 1 and AP-2 proteins inter-
act with the —87/—56 oligonucleotide, EMSAs were
performed with a combination of nuclear extracts pre-
pared 24 h after TPA treatment and recombinant AP-
2a protein as well as in the presence of AP-1 antisera.
Addition of recombinant AP-2a led to an induction of
complexes migrating similarly to C-C and possibly
FIG. 4. A: NPY promoter activation by overexpression of v-Jun.
Open columns represent the CAT activities obtained from tran-
sient transfections of untreated SH-SY5Y/wt cells with the —87/
—47 NPY/TKCAT reporter plasmid. Co-transfections with the
v-Jun activator plasmid are indicated below the columns. B:
Suppression of NPY promoter activity by a dominant negative
Jun plasmid. Co-transfections of TPA- and NGF-stimulated SH-
SY5Y/trk cells with the —87/—47 NPY/TKCAT plasmid and in-
creasing amounts (2 and 5 ~g) of a dominant negative Jun plas-
mid (~9).Open columns represent the relative CAT activities
obtained from TPA- and NGF-treated cells, respectively, in the
absence of the z~9plasmid. Hatched columns represent the fold
reduction of CAT activities obtained in co-transfections with ~9
plasmid. SH-SY5Y/trk cells were treated with 16 nM TPA or
with 100 ng/ml of NGF 24 h prior to harvest. Specificity of the
A9 plasmid was monitored using the positive pRSVCATplasmid
in separate co-transfections (not shown). Data represent an av-
erage of two transfections for each plasmid. The error bars repre-
sent the standard deviation from the mean. C: Inhibition of NPY
promoter activity by the selective PKC inhibitor GF 1 09203X.
Open columns represent the CAT activities obtained from tran-
sient transfections of untreated SH-SY5Y/trk cells with the —87/
—47 NPY/TKCAT reporter plasmid. Filled and hatched columns
represent activities obtained following TPA and NGF treatment,
respectively, 24 h prior to harvest. In these cultures, GF 1 09203X
was added 30 mm prior to NGF or TPA stimulation (indicated
below the bars) and was present during the following 24 h until
harvest of the transfected cells.
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in specific competition of C-C (Fig. SB, lane B). Thus,
AP-2a is clearly involved in the in vitro formation of
the C-C complex. Postincubation with an antiserum
broadly reactive with c-Jun, JunB, and JunD resulted
in a supershifted complex and concomitant disappear-
ance of C-C (Fig. SB, lane C), whereas antisera spe-
cific for c-Jun, JunD, and c-Fos, respectively, did not
reproducibly affect the C-C complex (Fig. SB, lanes
D—F). We conclude that both AP-2a and JunB or
an unknown Jun family member participates in the
formation of the C-C complex. The specificities of the
different antisera were analyzed usinga consensus AP-
1 oligonucleotide (no. 4 in Table 1) as well as unre-
lated oligonucleotides and nuclear extracts prepared
from SH-SY5Y/wt cells (data not shown).
FIG. 5. EMSA of proteins that bind to the NPYpromoter. A Nuclear
extracts prepared from TPA-treated SH-SY5Y/trk cells were incu-
bated with radioactively labeled double-stranded NPY promoter oh-
gonucleotides, —737—45 (no. 1, Table 1; lanes A—C) or —87/—56
(no. 2, Table 1; lanes D—F). Binding reactions in the presence of
100-fold molar excess amounts of nonradioactive competition ohigo-
nucleotides are indicated above the lanes. Specific DNA-protein
complexes Cl to CIV and C-A to C-C are indicated to the left and
right, respectively. NS, nonspecific complex. For nucleotide se-
quences of the oligonucleotides used, see Table 1. B: EMSA in the
presence of recombinant AP-2a (rAP-2a) and AP-1 antisera. Nuclear
extracts prepared from TPA-treated SH-SY5Y/wt cells were incu-
bated with the —877—56 NPY promoteroligonucleotide (no. 2, Table
1). In lane A, 0.01 fpu of rAP-2ct was included in the binding reaction.
Lane B, competition with an AP-2 ohigonucleotide (no. 7 in Table
1). In lanes C—F, binding was monitored in the presence of AP-1
antiserum added after the radioactive —877—56 oligonucleotide and
incubated on ice for 1 h. Lane C, a-c-Jun/AP-1 (D)/a-Jun (sc-44
X); lane D, a-JunD (sc-74 X); lane E, a-c-Jun (sc-45 X); lane F, a-
c-Fos (sc-52 X). The asterisk points to an anti-Jun supershifted
complex.
also to C-A (Fig. SB, lane A). Competition with an
AP-2 oligonucleotide (no. 7 in Table. 1) in the absence
of recombinant AP-2a in the binding reaction resulted
Analyses of proteins that bind to GSG elements
in NPY promoter
To investigate DNA binding activities to the GSG-
1 and GSG-2 elements located in the distal NGF RE
in the NPY promoter at positions —193 to —176 (Fig.
2), EMSA was performed using a GSG oligonucleo-
tide containing these two GSG boxes as well as an
AP-2 site overlapping GSG-l (no. S in Table 1 and
Fig. 2). Three distinct complexes denoted GSG-!, -I!,
and -III were obtained (Fig. 6A, lanes A and H). The
latter complex (GSG-III) was only weakly detectable.
The specificity of these complexes was revealed by
competition with an excess amount (200-fold molar
excess) of unlabeled GSG oligonucleotide (Fig. 6A,
lane F). Preincubation of the binding reaction with
200-fold molar excess of an oligonucleotide bearing
clustered mutations in the GSG boxes (no. 6 in Table
1) resulted in competition for GSG-! and -III, whereas
GSG-II binding activity was clearly detectable (Fig.
6A, lane G). We further analyzed whether recombi-
nant AP-2a could interact with this oligonucleotide,
as shown above for the —871—56 oligonucleotide (Fig.
5B). Incubation with recombinant AP-2cr alone failed
to generate a complex under these binding conditions
(Fig. 6A, lane B). However, incubation with nuclear
extracts prepared from NGF-treated SH-SY5Y/trk
cells together with different amounts of recombinant
AP-2ct resulted in a strong complex formation (Fig.
6A, lanes C and I). Also, GSG-II and -II! complexes
competed with an AP-2 oligonucleotide (no. 7 in Table
1; Fig. 6A, lane D). When 0.03 fpu of recombinant
AP-2a was added, a co-migration of the enhanced
complexes with the GSG-II and -II! complexes was
evident (Fig. 6A, lane I). Furthermore, the presence
of transcription factor AP-2a in the GSG-!I and -I!!
complexes was revealed by incubation with an AP-
2cr-specific antiserum that resulted in a supershift of
these complexes (Fig. 6A, lane J). Further, addition
of an SP1 oligonucleotide (no. 8 in Table 1) in the
binding reaction led to competition of GSG-! (Fig. 6A,
lane E). EMSA using an oligonucleotide correspond-
ing to the proximal GSG-3 element (see Fig. 2) failed
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NGFI-A (Crosby et al., 1991) were incubated together
with the GSG oligonucleotide (no. S in Table 1).
Prominent DNA binding activities were obtained upon
co-incubation of these two proteins with the GSG oh-
gonucleotide apparently generating the GSG-II and
-III complexes seen with the nuclear extracts (Fig. 6B,
lane B). NGFI-A alone in this binding reaction re-
sulted only in a weak protein-DNA interaction with a
size similar to the GSG-II complex (Fig. 6B, lane A).
When increasing amounts of NGFI-A were incubated
alone with’ the oligonucleotide, the formation of a dis-
tinct complex became evident (not shown). The coop-
eration between NGFI-A and other proteins binding to
this element (e.g., AP-2a) was revealed by addition of
in vitro translated NGFI-A to nuclear extracts prepared
from resting SH-SY5Y/trk cells. Compare lanes D and
E, where the latter lane contains in vitro translated
NGFI-A. Furthermore, a luciferase vector was used in
a parallel binding reaction to examine the specificity
of NGFI-A. Binding of in vitro translated luciferase to
the GSG oligonucleotide could not be obtained (not
shown). From these experiments we conclude that
transcription factors NGFI-Aand AP-2cr bind coopera-
tively to the GSG element in the NPY promoter.
DISCUSSION
FIG. 6. DNA-protein interactions at the GSG elements in the
NPY promoter. A: SH-SY5Y/trk nuclear extracts from NGF-
treated cells were incubated with the —195/ —173 NPY promoter
oligonucleotide (no. 5, Table 1). In lanes A—C and H—J, binding
reactions were without competitors. In lane B, 0.1 fpu of recom-
binant AP-2~(rAP-2a) was added alone; in lane C, it was com-
bined with nuclear extracts. In lanes D—G, GSG binding com-
peted with oligonucleotides as indicated. In a separate experi-
ment, 0.03 fpu of rAP-2a was added to the nuclear extract alone
(lane I). In lane J, an AP-2a-specific antiserum was included
after the binding reaction. B: In vitro translated NGFI-A (lane
A) and rAP-2a (lane C) were incubated alone with the GSG
ohigonucleotide (no. 5, Table 1). In lane B, NGFI-A and rAP-2a
were co-incubated. Lanes D and E, SH-SY5Y/trk nuclear ex-
tracts were incubated alone or co-incubated with in vitro trans-
lated NGFI-A.
to generate specific DNA binding activities (not
shown).
Cooperative interactions between AP-2a and
NGFI-A at distal GSG element in NPY promoter
To determine whether AP-2cr binds to the GSG box
together with previously identified GSG box binding
proteins, recombinant AP-2cr and in vitro translated
In this report, two NGF REs located at positions
—246 to —118 and —87 to —47 were demonstrated
to increase NPY transcription in activated SH-SYSY
neuroblastoma cells. The proximal NGF RE overlaps
with a TRE. Following NGF treatment, human SH-
SYSY/trk neuroblastoma cells differentiate to a func-
tional sympathetic neuronal phenotype accompanied
by enhanced NPY expression l~~vels(Lavenius et al.,
1995). Here we show that activation ofNPYtranscrip-
tion in response to 24-h NGF treatment occurs in SH-
SYSY/trk cells, whereas in SH-SYSY/wt cells, NPY
transcription was unaffected. Increased NPY transcrip-
tion was obtained by phorbol ester treatment of both
SH-SY5Y/wt and SH-SY5Y/trk cells. Thus, the
mechanisms involved in NGF-evoked NPY transcrip-
tion are defective in SH-SYSY/wt cells. Clustered
point mutations of the AP- 1 and AP-2 sites in the
proximal NGF RE/TRE abrogated the activation of
NPY transcription. In the distal NGF RE, two GSG
elements including a consensus AP-2 site were identi-
fied. GSG elements have been reported to be recog-
nized by the NGFI/Egr family of immediate early pro-
teins including NGFI-A/Egrl, Egr3, NGFI-C/Egr4,
and Egr2/Krox2O (Crosby et al., 1991; Swirnoff and
Milbrandt, 1995). Deletion of the GSG elements in
the distal NGF RE of the NPY promoter resulted in
decreased NOF responsiveness. These results revealed
that increases in rates of transcription from the NPY
promoter in response to NGF signaling are dependent
on both the proximal and the distal NGF REs. Induc-
tion of NGFI-A and NGFI-C mRNAs following brain
injury in regions where also AP-1 mRNA expression
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was enhanced has recently been reported (Honkaniemi
et al., 1995). In SH-SY5Y/trk cells, NGFI-A and
NGFI-C mRNA expression was induced in response
to both TPA and NGF treatment. Further, cooperative
DNA binding between AP-2a and NGFI-A proteins to
the GSG element located at positions — 193 to —176
was revealed.
We noted that NPY transcription is activated by
partly distinct mechanisms in response to phorbol es-
ter- and NGF-induced signaling. The selective PKC
inhibitor GF 109203X was administered in transfec-
tions of SH-SY5Y/trk cells with the —871----47 NPYI
TKCAT target plasmid. Almost a complete abrogation
of the TPA induction but only a partial suppression
of the transcriptional activation in response to NGF
treatment were obtained. Co-transfections with a v-
Jun activator plasmid with the —87/—47 NPY/TKCAT
target revealed that transcription factor AP-l activates
NPY gene transcription in these cells. Furthermore, the
dependence of transcription factor AP- 1 for NPY gene
expression in response to TPA and NGF was compared
by co-transfecting the —87/—47 NPYITKCAT target
with the dominant negative L~9Jun plasmid. In SH-
SYSY/trk cells, z~9strongly suppressed the TPA-in-
duced transcription from the NPY promoter. In con-
trast, NOF-evoked responses in SH-SYSY/trk cells
were affected to a lesser degree by the ~9 Jun plasmid.
These results clearly establish that AP-1 is essential
for activated NPY transcription in response to PKC
signaling and that partly distinct pathways are op-
erating to achieve transcriptional activation of the NPY
gene in response to NGF and TPA in SH-SY5Y cells.
Furthermore, binding of the differentiation-associ-
ated transcription factor AP-2a was shown to be essen-
tial for efficient binding of both AP-l and NGF!-A to
the NPY promoter. The two NGF REs in the NPY
promoter contain in total two perfect AP-2 sites (see
Fig. 2). In addition, an imperfect AP-2/GSG-like box
is located 3’ of the CT box (Fig. 2). Thus, interaction
of both AP-I and AP-2cr with the NPY promoter ap-
pears to be crucial for NPY expression as clustered
mutations of these promoter elements result in abol-
ished NPY promoter activity. Moreover, protein bind-
ing to the NPY promoter was monitored in the presence
of antisera specific for AP-1 proteins and revealed that
JunB or a related member of the AP- I family of tran-
scription factors binds to the AP-l-hike sites in the
NPY promoter (Figs. 2 and SB).
In conclusion, several lines of evidence underscore
the importance of the NGFI-A, AP- 1, and AP-2cr pro-
teins for NGF- and TPA-dependent NPY gene expres-
sion (Andersson et al., 1994; Minth-Worby, 1994; this
study). Furthermore, two NGF REs were shown to be
required for optimal NGF-evoked transcription of the
NPY gene. In both these NGF REs, transcription factor
AP-2a was shown to be involved in cooperative inter-
actions with NGFI-A and AP-1 proteins, respectively.
Transcription factor AP-2cr has recently been impli-
cated in inducing terminal differentiation and in inhib-
iting cancer cell growth by activation of p21 WAF/CIPI
expression (Zeng et al., 1997). Thus, the identification
of induced AP-2a activities during the onset of neu-
ronal differentiation further corroborates a crucial
function for this transcription factor in cell growth con-
trol and differentiation. Activation of transcription fac-
tor AP-2cr leads to a broad neuronal differentiation as
demonstrated by activated transcription of the NPY
gene in these neuroblastoma cells. We have shown that
AP-2a, NGFI-A, and AP-l cooperate to activate NPY
transcription in differentiating SH-SY5Y neuro-
blastoma cells. Further characterization of the mecha-
nisms by which these transcription factors become acti-
vated should reveal the functional consequences for
neuronal differentiation and growth control.
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